Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice

American Journal of Pathology

Volumn 171, Issue 6, 2007, Pages 2040-2047

  King, Victoria L ^a   Cassis, Lisa A ^a   Daugherty, Alan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; INTERLEUKIN 4; LOW DENSITY LIPOPROTEIN RECEPTOR; SATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; C57BL 6 MOUSE; CONTROLLED STUDY; DIET; FEMALE; GENETIC DISORDER; HYPERCHOLESTEROLEMIA; INTERLEUKIN 4 DEFICIENCY; LESIONS AND DEFECTS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; STIMULUS; STIMULUS RESPONSE;

EID: 38349004554     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060857     Document Type: Article

References (56)

1. Stemme S, Rymo L, Hansson GK: Polyclonal origin of lymphocytes-T in human atherosclerotic plaques. Lab Invest 1991, 65:654-660
2. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK: Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986, 6:131-138
3. Xu QB, Oberhuber G, Gruschwitz M, Wick G: Immunology of atherosclerosis: cellular composition and major histocompatibility complex class-II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol 1990, 56:344-359
4. -/- mice: decreasing density with disease progression. Arterioscler Thromb Vasc Biol 1996, 16:1013-1018
5. Munro JM, Van der Walt JD, Munro CS, Chalmers JAC, Cox EL: An immunohistochemical analysis of human aortic fatty streaks. Hum Pathol 1987, 18:375-380
6. Daugherty A, Hansson GK: Lymphocytes in atherogenesis. Atherosclerosis. Edited by RT Dean, D Kelly. Oxford, UK, Oxford Press, 2000, pp 230-249
7. Hansson GK, Jonasson L, Lojsthed B, Stemme S, Kocher O, Gabbiani G: Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. Atherosclerosis 1988, 72:135-141
8. Hansson GK, Holm J, Jonasson L: Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989, 135:169-175
9. de Boer OJ, Van der Wal AC, Verhagen CE, Becker AE: Cytokine secretion profiles of cloned T cells from human aortic atherosclerotic plaques. J Pathol 1999, 188:174-179
10. Kishikawa H, Shimokama T, Watanabe T: Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima: role of cell-mediated immunity in human atherogenesis. Virchows Archiv A Pathol Anat 1993, 423:433-442
11. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK: T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995, 92:3893-3897
12. Gupta S, Pablo AM, Jiang XC, Wang N, Tall AR, Schindler C: IFNgamma potentiates atherosclerosis in apoE knock-out mice. J Clin Invest 1997, 99:2752-2761
13. -/- mice. Am J Pathol 2000, 157:1819-1824
14. -/- mice. J Interferon Cytokine Res 2002, 22:661-670
15. Buono C, Come CE, Stavrakis G, Maguire GF, Connelly PW, Lichtman AH: Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler Thromb Vasc Biol 2003, 23:454-460
16. Davenport P, Tipping PG: The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2003, 163:1117-1125
17. Whitman SC, Ravisankar P, Daugherty A: Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ Res 2002, 90:E34-E38
18. Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y, Tedgui A: Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001, 104:1598-1603
19. Elhage R, Jawien J, Rudling M, Ljunggren HG, Takeda K, Akira S, Bayard F, Hansson GK: Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 2003, 59:234-240
20. Sad S, Marcotte R, Mosmann TR: Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 1995, 2:271-279
21. Lee TS, Yen HC, Pan CC, Chau LY: The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 1999, 19:734-742
22. Yoshimoto T, Paul WE: CD4pos, NK11pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 1994, 179:1285-1295
23. Zhou XH, Paulsson G, Stemme S, Hansson GK: Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest 1998, 101:1717-1725
24. Nicoletti A, Kaveri S, Caligiuri G, Bariety J, Hansson GK: Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest 1998, 102:910-918
25. Sasaguri T, Arima N, Tanimoto A, Shimajiri S, Hamada T, Sasaguri Y: A role for interleukin 4 in production of matrix metalloproteinase 1 by human aortic smooth muscle cells. Atherosclerosis 1998, 138:247-253
26. Feng JW, Han JH, Pearce SFA, Silverstein RL, Gotto AM, Hajjar DP, Nicholson AC: Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res 2000, 41:688-696
27. Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, Witztum JL, Funk CD, Conrad D, Glass CK: Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999, 400:378-382
28. Cornicelli JA, Butteiger D, Rateri DL, Welch K, Daugherty A: Interleukin-4 augments acetylated LDL induced cholesterol esterification in macrophages. J Lipid Res 2000, 41:376-383
29. Barks JL, McQuillan JJ, Iademarco MF: TNF-alpha and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells. J. Immunol 1997, 159:4532-4538
30. Lee YW, Kuhn H, Hennig B, Neish AS, Toborek M: IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells. J Mol Cell Cardiol 2001, 33:83-94
31. Walch L, Massade L, Dufilho M, Brunet A, Rendu F: Pro-atherogenic effect of interleukin-4 in endothelial cells: modulation of oxidative stress, nitric oxide and monocyte chemoattractant protein-1 expression. Atherosclerosis 2006, 187:285-291
32. Woszczek G, Pawliczak R, Qi HY, Nagineni S, Alsaaty S, Logun C, Shelhamer JH: Functional characterization of human cysteinyl leukotriene 1 receptor gene structure. J Immunol 2005, 175:5152-5159
33. Conrad DJ, Kuhn H, Mulkins M, Highland E, Sigal E: Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sci USA 1992, 89:217-221
34. Lee YW, Kuhn H, Kaiser S, Hennig B, Daugherty A, Toborek M: Interleukin 4 induces transcription of the 15-lipoxygenase I gene in human endothelial cells. J Lipid Res 2001, 42:783-791
35. Vasse M, Paysant I, Soria J, Mirshahi SS, Vannier JP, Soria C: Downregulation of fibrinogen biosynthesis by IL-4, IL-10 and IL-13. Br J Haematol 1996, 93:955-961
36. George J, Mulkins M, Shaish A, Casey S, Schatzman R, Sigal E, Harats D: Interleukin (IL)-4 deficiency does not influence fatty streak formation in C57BL/6 mice. Atherosclerosis 2000, 153:403-411
37. George J, Shoenfeld Y, Gilburd B, Afek A, Shaish A, Harats D: Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis. Circ Res 2000, 86:1203-1210
38. -/- mice. Arterioscler Thromb Vasc Biol 2002, 22:456-461
39. Zhang SH, Reddick RL, Piedrahita JA, Maeda N: Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471
40. Plump AS, Smith JD, Hayek T, Aaltosetala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL: Severe hypercholesterolemia and atherosclerosis in apolipoprotein-E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71:343-353
41. Daugherty A, Manning MW, Cassis LA: Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000, 105:1605-1612
42. Cameron MJ, Arreaza GA, Zucker P, Chensue SW, Strieter RM, Chakrabarti S, Delovitch TL: IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J Immunol 1997, 159:4686-4692
43. -/- mice. Ann NY Acad Sci 1999, 892:108-118
44. Sendobry SM, Cornicelli JA, Welch K, Bocan T, Tait B, Trivedi BK, Colbry N, Dyer RD, Feinmark SJ, Daugherty A: Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties. Br J Pharmacol 1997, 120:1199-1206
45. Daugherty A, Whitman SC: Quantification of atherosclerosis in mice. Methods Mol Biol 2003, 209:293-309
46. Saraff K, Babamusta F, Cassis LA, Daugherty A: Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003, 23:1621-1626
47. Wouters K, Shiri-Sverdlov R, van Gorp PJ, van Bilsen M, Hofker MH: Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and IdIr mice. Clin Chem Lab Med 2005, 43:470-479
48. Daugherty A: Mouse models of atherosclerosis. Am J Med Sci 2002, 323:3-10
49. Dansky HM, Charlton SA, Harper MM, Smith JD: T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 1997, 94:4642-4646
50. -/- mice. J Clin Invest 1997, 100:1575-1580
51. Weiss D, Kools JJ, Taylor WR: Angiotensin II-induced hypertension accelerates the development of atherosclerosis in ApoE-deficient mice. Circulation 2001, 103:448-454
52. Tangirala RK, Rubin EM, Palinski W: Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 1995, 36:2320-2328
53. King VL, Szilvassy SJ, Daugherty A: Interleukin-4 deficiency promotes gallstone formation. J Lipid Res 2002, 43:768-771
54. Schiller NK, Kubo N, Boisvert WA, Curtiss LK: Effect of gamma-irradiation and bone marrow transplantation on atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2001, 21:1674-1680
55. Huber SA, Sakkinen P, David C, Newell MK, Tracy RP: T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation 2001, 103:2610-2616
56. Schönbeck U, Sukhova GK, Gerdes N, Libby P: T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm. Am J Path 2002, 161:499-506